|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 癫痫患者P50听觉诱发电位的研究显示文摘目的 探讨 P5 0在癫痫患者检测中的临床价值。方法 对 2 5例癫痫患者 (其中 7例额叶癫痫 ;18例颞叶癫痫 )进行 P5 0测试 ,分析 P5 0波的潜伏期和波幅 (峰峰值 )以及在不同刺激频率时 P5 0波幅 (峰峰值 )的比率。选择年龄、性别与患者组相匹配的 2 5名健康受试者对照组。结果 癫痫患者组 P5 0波的潜伏期较长 ,波幅则显著减低 ,其中以 18例颞叶癫痫患者表现显著 ,7例额叶癫痫患者不明显。刺激频率稍加快时 ,患者组 P5 0的波幅比率明显减小。结论 P5 0波的潜伏期和波幅反应异常与颞叶功能障碍密切相关 ,可帮助临床鉴别额、颞叶癫痫灶 ;其波幅衰减现象似与癫痫发作间期行为和认知改变相关 ,但也可能受药物的影响。 | 童晓欣 Miles E. Drake Jr | 2000 | 华中医学杂志2000，24，4： | 2 |
| 2 | Influence of sleep deprivation and circadi- an mis-alignment on cortisol, inflammatory markers, and cytokine balance 显示文摘 | Wright KP Jr Drake AL Frey D J | 2015 | BrainBehav Immun2015，47，： | 1 |
| 3 | Phase I study of single-agent anti-programmed death-1(MDX-1106)in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 4 | Phase I study of single-agent anti-progTammed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 5 | Phase I study of single agent anti-programmed death-1 (MDX-1106) in refractory solid tumors : safety, clinical activity, pharrnacodynamies, and immunologic correlates显示文摘 | Brabmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 6 | Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors:safety, clinical activity, pharmacodynamics, and immunologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 7 | Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance 显示文摘 | Wright KP Jr Drake AL Frey D J | 2015 | Brain BehavImmun2015，47，： | 1 |
| 8 | Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus 显示文摘 | Drake JM Kestle JR Milner R | 1998 | Neurosurgery1998，43，2： | 1 |
| 9 | CSF shunts 50 years on-past,present and future显示文摘 | Drake JM Kestle JR Tuli S | 2000 | Childs Nerv Syst2000，16，1011： | 1 |
| 10 | Phase Ⅰ study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 11 | Prostate cancer immuno-therapy显示文摘 | May KF Jr Gulley JL Drake CG | 2011 | Clin Cancer Res2011，17，16： | 1 |
| 12 | Randomized trial ofcerebrospinal fluid shunt valve design in pediatric hydrocephalus显示文摘 | Drake JM Kestle JR Milner R | 1998 | Neurosurgery1998，43，2： | 1 |
| 13 | Phase Ⅰ study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immunologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 14 | Phase I study ofsingle-agent anti-programmed death-1 (MDX-1106) inrefractory solid tumors: safety, clinical activity,pharmacodynamics, and immunologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J ClinOncol2010，28，19： | 1 |
| 15 | Evolution of Industrial laser-Ultrasonic Systems for the Inspection of Composites 显示文摘 | MARC Dubois THOMAS E DRAKE Jr | 2011 | Non- destructive Testing and Evaluation2011，26，： | 1 |
| 16 | Spectral analysis of EEG photic driving in epilepsy显示文摘 | Tong X Drake ME Jr | 1997 | Epilepsia1997，8，： | 1 |
| 17 | Phase I study of sin- gle-agent anti-programmed death-1 (MDX-1106) in refractory sol-id tumors: Safety, clinical activity, pharmacodynamics, and im- munologic correlates 显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
| 18 | Organization, barrier func- tion and antimicrobial lipids of the oral mucosa 显示文摘 | Dawson DV Drake DR Hill JR | 2013 | Int J Cosmet Scien2013，10，1： | 1 |
| 19 | Phase I study of single -a- gent anti - programmed death -1( MDX -1106) in refractory sol- id tumors:safety,clinical activity,pharmacodynamics,and im- munologic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin OncoI2010，28，19： | 1 |
| 20 | Phase I study of single - a- gent anti - programmed death -1( MDX -1106) in refractory solid tumors:safety,clinical activity,pharmacodynamics,and immuno- logic correlates显示文摘 | Brahmer JR Drake CG Wollner I | 2010 | J Clin Oncol2010，28，19： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员